Reiswich et al.GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors. Published in Pathobiology. 2023 Jan 17:1-14. doi: 10.1159/000527382. Epub ahead of print. PMID: 36649695.
Viehweger et al. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors. Pathol Res Pract. 2022 Nov 5;240:154200. doi: 10.1016/j.prp.2022.154200. Epub ahead of print. PMID: 36375372.
Weidemann et al. Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors. Biomedicines. 2022 Oct 7;10(10):2507. doi: 10.3390/biomedicines10102507. PMID: 36289769; PMCID: PMC9598868.
Lennartz et al. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors. APMIS. 2022 Oct 21. doi: 10.1111/apm.13280. Epub ahead of print. PMID: 36269681.
Lennartz et al. Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells. Diagnostics (Basel). 2022 Oct 17;12(10):2516. doi: 10.3390/diagnostics12102516. PMID: 36292206; PMCID: PMC9600073.
Uhlig et al. Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors. Pathol Res Pract. 2022 Sep 15;238:154123. Epub ahead of print. PMID: 36137400.
Uhlig et al. Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors. Ann Diagn Pathol. 2022 Aug 20;60:152029. Epub ahead of print. PMID: 36029589.
Viehweger et al. Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors. Anal Cell Pathol (Amst). 2022 Aug 8;2022:6412148. PMID: 35992051
Dum et al. “FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.” Virchows Arch. 2022 Aug 11. doi: 10.1007/s00428-022-03394-5. Epub ahead of print. PMID: 35951102.
Menz et al. “Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.” Int J Surg Pathol. 2022 Aug 9:10668969221117243. doi: 10.1177/10668969221117243. Epub ahead of print. PMID: 35946088.
Uhlig et al. “Synaptophysin and chromogranin A expression analysis in human tumors.” Mol Cell Endocrinol. 2022 Jul 31;555:111726. doi: 10.1016/j.mce.2022.111726. Epub ahead of print. PMID: 35921917.
Reiswich et al. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer. Published in Pathology Research and Practice 2022 Jul 18;237:154028. doi: 10.1016/j.prp.2022.154028. Epub ahead of print. PMID: 35872365.
Dum et al. “Villin expression in human tumours: a tissue microarray study on 14,398 tumours.” Expert Rev Mol Diagn. 2022 Jul 22. doi: 10.1080/14737159.2022.2104122. Epub ahead of print. PMID: 35866621.
De Wispelaere et al. High prevalence of p16 staining in malignant tumors. PLoS One. 2022 Jul 21;17(7):e0262877. doi: 10.1371/journal.pone.0262877. PMID: 35862385;
Reiswich et al. „Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology. “Published in Human Pathology. 2022 May 10;126:108-120. PMID: 35550834.
Dum et al. “Trophoblast cell surface antigen 2 (TROP2) expression in human tumors: A tissue microarray study on 18,563 tumors.” Published in Pathobiology. 2022 Apr 27:1-14. PMID: 35477165.
Dum et al. “ Dum et al. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Exp Mol Pathol. 2022 Apr 4;126:104762. doi: PMID: 35390310.
Dum et al. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence. Lab Invest. 2022 Jan 29. PMID: 35091676.
Dwertmann et al Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221106504. PMID: 35764407
